Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
PBM
PSYENCE BIOMEDICAL LTD
NASDAQ
Biotechnology
$2.92M$5.143.53%$1.03M0.98x0.09
Canada
ZBIO
ZENAS BIOPHARMA INC
NASDAQ
Biotechnology
$467.71M$11.18-7.37%N/AN/A0.17
United States
BSGM
BIOSIG TECHNOLOGIES INC
NASDAQ
Medical Devices
$284.14M$10.417.88%-$9.32M-17.64x0.65
United States
TNXP
TONIX PHARMACEUTICALS HOLDING CORP
NASDAQ
Biotechnology
$299.36M$40.87-3.52%-$129.22M-0.02x0.07
United States
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.29B$14.75-10.96%-$3.56M-1,638.89x0.03
Hong Kong
TLSA
TIZIANA LIFE SCIENCES LTD
NASDAQ
Biotechnology
$164.96M$1.480.68%-$16.62M-13.45x1.87
United Kingdom
NRSN
NEUROSENSE THERAPEUTICS LTD
NASDAQ
Biotechnology
$48.08M$2.07-1.90%-$10.19M-3.83x0.77
Israel
LUNG
PULMONX CORP
NASDAQ
Medical Devices
$116.75M$2.909.43%-$50.39M-2.01x0.94
United States
JYNT
JOINT CORP
NASDAQ
Medical Care Facilities
$177.51M$11.60-2.03%-$4.68M-20.00x2.88
United States
MGTX
MEIRAGTX HOLDINGS PLC
NASDAQ
Biotechnology
$680.69M$8.47-1.74%-$141.63M-3.65x5.77
United States
TCRX
TSCAN THERAPEUTICS INC
NASDAQ
Biotechnology
$102.43M$1.81-1.63%-$124.58M-1.66x0.58
United States
ORKA
ORUKA THERAPEUTICS INC
NASDAQ
Biotechnology
$532.78M$14.231.14%-$77.36M-7.86x0.03
United States
LUCY
INNOVATIVE EYEWEAR INC
NASDAQ
Medical Instruments & Supplies
$6.56M$2.12-0.47%-$7.42M-0.53x0.06
United States
LENZ
LENZ THERAPEUTICS INC
NASDAQ
Biotechnology
$976.39M$34.691.26%-$47.65M78.84x0.05
United States
IBRX
IMMUNITYBIO INC
NASDAQ
Biotechnology
$2.48B$2.81-2.09%-$240.81M-5.20x-1.51
United States
ANAB
ANAPTYSBIO INC
NASDAQ
Biotechnology
$769.77M$26.200.42%-$138.18M-5.47x11.41
United States
BLCO
BAUSCH & LOMB CORP
NYSE
Medical Instruments & Supplies
$4.91B$13.88-2.25%$493.00M-13.48x1.10
Canada
ABEO
ABEONA THERAPEUTICS INC
NASDAQ
Biotechnology
$293.64M$5.74-1.88%-$36.93M-7.00x1.40
United States
ALUR
ALLURION TECHNOLOGIES INC
NYSE
Medical Devices
$21.18M$2.84-5.02%-$21.67M-0.23x-1.55
United States
CTEV
CLARITEV CORP
NYSE
Health Information Services
$761.33M$46.32-2.73%-$523.35M-0.64x341.97
United States
TAK
TAKEDA PHARMACEUTICAL CO LTD
NYSE
Drug Manufacturers - Specialty & Generic
$46.20B$14.68-1.08%$7.92B62.20x1.05
Japan
SMMT
SUMMIT THERAPEUTICS INC
NASDAQ
Biotechnology
$18.57B$25.00-3.40%-$231.98M-8,333.33x0.12
United Kingdom
NDRA
ENDRA LIFE SCIENCES INC
NASDAQ
Diagnostics & Research
$5.98M$8.101.25%-$9.57M-0.06x0.81
United States
OMDA
OMADA HEALTH INC
NASDAQ
Health Information Services
N/A$17.67-1.40%N/AN/A-0.21
United States
LYEL
LYELL IMMUNOPHARMA INC
NASDAQ
Biotechnology
$143.98M$9.75-0.20%-$316.47M-0.39x0.28
United States
VNDA
VANDA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$279.35M$4.74-5.01%-$47.73M-6.24x0.24
United States
EVAX
EVAXION A
NASDAQ
Biotechnology
$3.73M$2.663.10%-$8.23M-0.27x-8.56
Denmark
GERN
GERON CORP
NASDAQ
Biotechnology
$840.73M$1.32-4.35%-$114.49M-6.29x1.10
United States
AIRS
AIRSCULPT TECHNOLOGIES INC
NASDAQ
Medical Care Facilities
$292.72M$4.98-0.20%-$2.09M-17.17x1.63
United States
INMB
INMUNE BIO INC
NASDAQ
Biotechnology
$53.62M$2.313.59%-$40.80M-1.20x0.27
United States
SSII
SS INNOVATIONS INTERNATIONAL INC
NASDAQ
Medical Devices
$966.08M$4.99-6.90%-$18.05M-45.36x0.57
United States
XNCR
XENCOR INC
NASDAQ
Biotechnology
$628.44M$8.83-4.85%-$158.22M-2.90x0.41
United States
SDGR
SCHRODINGER INC
NASDAQ
Health Information Services
$1.54B$21.01-3.22%-$175.90M-7.99x0.99
United States
NAMS
NEWAMSTERDAM PHARMA CO NV
NASDAQ
Biotechnology
$2.42B$21.54-2.18%-$210.35M-10.20x0.05
Netherlands
IMMX
IMMIX BIOPHARMA INC
NASDAQ
Biotechnology
$73.87M$2.65-2.21%-$20.70M-3.79x1.07
United States
UNCY
UNICYCIVE THERAPEUTICS INC
NASDAQ
Biotechnology
$60.44M$5.01-4.57%-$14.91M-2.18x1.48
United States
BDRX
BIODEXA PHARMACEUTICALS PLC
NASDAQ
Biotechnology
$0.00$0.87-1.69%-$7.32M-6.62x0.78
United Kingdom
NNNN
ANBIO BIOTECHNOLOGY
NASDAQ
Biotechnology
$7.01B$49.26-2.91%$2.37M879.64x0.10
Germany
HUMA
HUMACYTE INC
NASDAQ
Biotechnology
$358.32M$2.31-7.97%-$59.92M-3.35x3.51
United States
INO
INOVIO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$49.88M$1.36-2.16%-$93.37M-0.43x0.70
United States
ALZN
ALZAMEND NEURO INC
NASDAQ
Biotechnology
$2.35M$3.204.92%-$4.16M-0.12x0.21
United States
MBOT
MICROBOT MEDICAL INC
NASDAQ
Medical Instruments & Supplies
$95.31M$2.62-0.76%-$11.60M-4.03x0.07
United States
RMTI
ROCKWELL MEDICAL INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$38.62M$1.13-12.40%$4.97M-56.50x0.71
United States
CCCC
C4 THERAPEUTICS INC
NASDAQ
Biotechnology
$158.35M$2.2312.06%-$94.83M-1.52x0.64
United States
HROW
HARROW INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.28B$34.9311.35%$18.65M-57.26x5.46
United States
ATYR
ATYR PHARMA INC
NASDAQ
Biotechnology
$471.72M$5.30-0.56%-$62.26M-6.63x0.30
United States
ENTA
ENANTA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$140.23M$6.56-6.02%-$87.12M-1.44x2.45
United States
PACS
PACS GROUP INC
NYSE
Medical Care Facilities
$1.93B$12.68-0.86%N/AN/A5.80
United States
NVNO
ENVVENO MEDICAL CORP
NASDAQ
Medical Devices
$73.30M$4.18-3.24%-$20.82M-3.54x0.06
United States
LXRX
LEXICON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$392.23M$1.08-4.42%-$164.27M-2.12x1.42
United States
AVIR
ATEA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$314.08M$3.67-2.91%-$138.18M-2.22x0.07
United States
ICU
SEASTAR MEDICAL HOLDING CORP
NASDAQ
Biotechnology
$6.25M$0.59-3.58%-$15.79M-0.19x12.45
United States
IRD
OPUS GENETICS INC
NASDAQ
Biotechnology
$67.42M$1.130.89%-$58.60M-0.54x4.78
United States
CTKB
CYTEK BIOSCIENCES INC
NASDAQ
Medical Devices
$436.97M$3.45-3.09%$8.03M0.00x0.27
United States
COEP
COEPTIS THERAPEUTICS HOLDINGS INC
NASDAQ
Biotechnology
$33.28M$9.47-0.32%-$8.51M-1.84x0.93
United States
ALGS
ALIGOS THERAPEUTICS INC
NASDAQ
Biotechnology
$51.12M$8.36-4.89%-$68.53M-0.81x0.29
United States
FGEN
FIBROGEN INC
NASDAQ
Biotechnology
$28.90M$7.15-2.72%-$2.60M-2.86x-1.57
United States
CAMP
CAMP4 THERAPEUTICS CORP
NASDAQ
Biotechnology
$30.24M$1.50-2.60%N/AN/A0.22
United States
IINN
INSPIRA TECHNOLOGIES OXY BHN LTD
NASDAQ
Medical Devices
$29.10M$1.20-12.41%-$10.84M-2.00x0.87
Israel
ACTU
ACTUATE THERAPEUTICS INC
NASDAQ
Biotechnology
$120.46M$6.14-0.65%-$25.29M-1.59x-1.88
United States
GHRS
GH RESEARCH PLC
NASDAQ
Biotechnology
$984.39M$15.87-1.12%-$41.08M-20.09x0.03
Ireland
IFRX
INFLARX NV
NASDAQ
Biotechnology
$59.62M$0.88-1.68%-$50.25M-1.03x0.24
Germany
VCEL
VERICEL CORP
NASDAQ
Biotechnology
$2.01B$39.93-3.15%$16.81M798.60x0.44
United States
SERA
SERA PROGNOSTICS INC
NASDAQ
Diagnostics & Research
$106.99M$2.842.90%-$31.55M-3.02x0.25
United States
EVO
EVOTEC SE
NASDAQ
Drug Manufacturers - Specialty & Generic
$1.45B$4.07-2.40%N/AN/A1.13
Germany
LQDA
LIQUIDIA CORP
NASDAQ
Biotechnology
$1.20B$14.09-0.42%-$110.63M-8.92x3.58
United States
NIVF
NEWGENIVF GROUP LTD
NASDAQ
Medical Care Facilities
$7.14k$0.630.16%-$26.43k-0.05x-4.83
Thailand
LIMN
LIMINATUS PHARMA INC
NASDAQ
Biotechnology
$173.00M$6.65-7.64%N/AN/A-1.31
United States
ELAB
PMGC HOLDINGS INC
NASDAQ
Biotechnology
$3.04M$2.21-2.64%-$5.74M0.08x0.09
United States
CGON
CG ONCOLOGY INC
NASDAQ
Biotechnology
$2.04B$26.72-1.44%-$105.54M-17.70x0.03
United States
QTTB
Q32 BIO INC
NASDAQ
Biotechnology
$32.45M$2.66-19.88%-$58.70M-0.54x-20.70
United States
TRVI
TREVI THERAPEUTICS INC
NASDAQ
Biotechnology
$666.43M$6.552.18%-$47.23M-14.56x0.08
United States
BIVI
BIOVIE INC
NASDAQ
Biotechnology
$13.25M$7.14-5.68%-$17.90M-0.44x0.13
United States
HOTH
HOTH THERAPEUTICS INC
NASDAQ
Biotechnology
$19.02M$1.44-3.36%-$9.62M-1.26x0.07
United States
NOTV
INOTIV INC
NASDAQ
Diagnostics & Research
$69.05M$2.01-4.74%$5.65M-0.63x3.86
United States
HYPD
HYPERION DEFI INC
NASDAQ
Biotechnology
$38.14M$13.235.08%-$39.04M-0.30x-1.62
United States
RLAY
RELAY THERAPEUTICS INC
NASDAQ
Biotechnology
$617.20M$3.60-3.49%-$328.11M-1.64x0.11
United States
MREO
MEREO BIOPHARMA GROUP PLC
NASDAQ
Biotechnology
$255.99M$1.61-4.73%-$46.22M-4.60x0.14
United Kingdom
ALLR
ALLARITY THERAPEUTICS INC
NASDAQ
Biotechnology
$15.23M$1.01-6.48%-$23.16M-0.64x0.59
United States
TNON
TENON MEDICAL INC
NASDAQ
Medical Devices
$7.74M$1.02-6.42%-$13.11M-0.19x0.43
United States
NRXS
NEURAXIS INC
NYSEMKT
Biotechnology
$17.32M$2.40-0.41%-$8.19M-1.98x10.72
United States
BBIO
BRIDGEBIO PHARMA INC
NASDAQ
Biotechnology
$8.82B$46.470.43%-$539.06M-13.09x-1.53
United States
STSS
SHARPS TECHNOLOGY INC
NASDAQ
Medical Instruments & Supplies
$5.84M$5.73-2.39%-$3.41M-0.00x0.87
United States
OM
OUTSET MEDICAL INC
NASDAQ
Medical Devices
$343.64M$19.39-5.92%-$84.88M-0.67x0.77
United States
ZVSA
ZYVERSA THERAPEUTICS INC
NASDAQ
Biotechnology
$2.82M$0.590.00%-$8.44M-0.11x1.58
United States
ACHC
ACADIA HEALTHCARE COMPANY INC
NASDAQ
Medical Care Facilities
$2.24B$24.36-1.34%$527.94M11.94x0.98
United States
SBFM
SUNSHINE BIOPHARMA INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$7.02M$1.54-3.45%-$5.07M-0.31x0.29
United States
MDWD
MEDIWOUND LTD
NASDAQ
Biotechnology
$216.29M$20.03-5.03%-$18.84M-9.82x1.21
Israel
GLMD
GALMED PHARMACEUTICALS LTD
NASDAQ
Biotechnology
$3.20M$1.94-4.68%-$7.82M-0.27x0.11
Israel
KIDS
ORTHOPEDIATRICS CORP
NASDAQ
Medical Devices
$542.19M$21.89-2.49%-$19.85M-12.44x0.36
United States
RCEL
AVITA MEDICAL INC
NASDAQ
Medical Devices
$150.68M$5.70-4.04%-$49.49M-2.60x-16.20
United States
MGNX
MACROGENICS INC
NASDAQ
Biotechnology
$101.58M$1.611.90%-$48.21M-1.81x1.84
United States
IMNN
IMUNON INC
NASDAQ
Biotechnology
$8.85M$0.61-6.92%-$17.06M-0.44x14.18
United States
GNLX
GENELUX CORP
NASDAQ
Biotechnology
$129.43M$3.43-0.29%-$28.55M-3.90x0.31
United States
IBO
IMPACT BIOMEDICAL INC
NYSEMKT
Biotechnology
$7.11M$0.592.62%-$22.76M-0.25x3.45
United States
PGEN
PRECIGEN INC
NASDAQ
Biotechnology
$540.18M$1.83-4.19%-$154.85M-3.27x-8.06
United States
TECX
TECTONIC THERAPEUTIC INC
NASDAQ
Biotechnology
$422.65M$22.644.21%-$55.94M-3.69x0.05
United States
SPRY
ARS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.74B$17.69-1.61%-$15.01M-104.06x0.43
United States
GALT
GALECTIN THERAPEUTICS INC
NASDAQ
Biotechnology
$158.86M$2.512.45%-$38.92M-3.49x-1.07
United States
ACB
AURORA CANNABIS INC
NASDAQ
Drug Manufacturers - Specialty & Generic
$252.49M$4.49-4.26%$26.15M154.83x0.43
Canada
1...456...12

Healthcare Industries

IndustryStocks1d %1w %1m %1y %DD ScoreP/E ratioP/B RatioROEROAROCEUpside/DownsideConsensus
647-0.68%+5.06%+4.43%-70.68%-154.99x4.62x-78.69%-3.60%+4.46%+93.17%Strong Buy
57-1.08%+1.46%+2.25%-16.73%20.92x3.66x-11.22%+6.00%+10.82%+12.46%Buy
18-0.94%+1.72%-0.28%-12.76%38.63x6.05x+50.91%+9.84%+16.78%+50.62%Buy
77-1.74%+1.28%-0.66%-67.49%-18.61x2.20x+9.72%+4.80%+10.86%+40.70%Buy
11-1.15%-2.51%-9.15%-30.24%13.33x1.90x+16.91%+5.33%+12.34%+36.12%Buy
56-2.27%-2.63%-1.67%-66.15%42.35x3.91x+8.09%+4.35%+9.43%+25.78%Strong Buy
48-0.91%-0.46%-3.43%-13.85%15.96x4.55x-73.74%+6.76%+14.29%+24.03%Buy
140-2.46%-0.19%-2.00%-24.69%35.68x4.06x+7.24%+8.24%+8.90%+31.36%Strong Buy
10-0.77%-3.11%+0.94%+26.96%28.41x1,368.33x+0.77%+3.59%+22.76%+8.72%Buy
55-2.17%-0.10%-0.39%-59.94%38.69x3.63x+10.20%+8.33%+10.95%+23.73%Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) is the #1 top healthcare stock out of 1119 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Phibro Animal Health (NASDAQ:PAHC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: C, and AI: B.

Phibro Animal Health (NASDAQ:PAHC) has a Due Diligence Score of 45, which is 19 points higher than the healthcare sector average of 26. It passed 16 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock return 76% over the past year, overperforming other healthcare stocks by 129 percentage points.

Phibro Animal Health has an average 1 year price target of $27.67, a downside of -10.17% from Phibro Animal Health's current stock price of $30.80.

Phibro Animal Health stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Phibro Animal Health, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a Hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

2. Enhabit (NYSE:EHAB)


Enhabit (NYSE:EHAB) is the #2 top healthcare stock out of 1119 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Enhabit (NYSE:EHAB) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: A, Financials: B, and AI: B.

Enhabit (NYSE:EHAB) has a Due Diligence Score of 7, which is -19 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates EHAB as a "A".It passed 2 out of 33 due diligence checks and has weak fundamentals. Enhabit has seen its stock lose -23.78% over the past year, overperforming other healthcare stocks by 29 percentage points.

3. Cumberland Pharmaceuticals (NASDAQ:CPIX)


Cumberland Pharmaceuticals (NASDAQ:CPIX) is the #3 top healthcare stock out of 1119 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Cumberland Pharmaceuticals (NASDAQ:CPIX) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: C, Financials: B, and AI: C.

Cumberland Pharmaceuticals (NASDAQ:CPIX) has a Due Diligence Score of 23, which is -3 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates CPIX as a "A".It passed 7 out of 33 due diligence checks and has weak fundamentals. Cumberland Pharmaceuticals has seen its stock return 108.33% over the past year, overperforming other healthcare stocks by 161 percentage points.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)


Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 12.9%, which is 11 percentage points higher than the healthcare sector average of 1.99%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 32.4% indicates that its high dividend yield is sustainable for the long-term.

2. Cryo Cell International (NYSEMKT:CCEL)


Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of 8.33%, which is 6 percentage points higher than the healthcare sector average of 1.99%.

Cryo Cell International's dividend payout ratio of 5,000% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)


Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 7.19%, which is 5 percentage points higher than the healthcare sector average of 1.99%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 160.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -1.29% in the last day, and up 1.44% over the last week. Milestone Pharmaceuticals was the among the top losers in the healthcare sector, dropping -39.06% yesterday.

Milestone Pharmaceuticals shares are trading lower after the company announced a $52.5 million offering.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Centene (NYSE:CNC)


Centene (NYSE:CNC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Centene has a valuation score of 43, which is 26 points higher than the healthcare sector average of 17. It passed 3 out of 7 valuation due diligence checks.

Centene's stock has dropped -53.25% in the past year. It has performed in line with other stocks in the healthcare sector.

2. Puma Biotechnology (NASDAQ:PBYI)


Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 26 points higher than the healthcare sector average of 17. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -1.45% in the past year. It has overperformed other stocks in the healthcare sector by 51 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)


Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 54 points higher than the healthcare sector average of 17. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 2.04% in the past year. It has overperformed other stocks in the healthcare sector by 55 percentage points.

Are healthcare stocks a good buy now?

50.66% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 46.49% over the next year.

5.02% of healthcare stocks have a Zen Rating of A (Strong Buy), 10.99% of healthcare stocks are rated B (Buy), 45.28% are rated C (Hold), 26.4% are rated D (Sell), and 12.31% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 1.57x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.